Patent · US Active

Corroles for treating human cytomegalovirus infections

US11395816B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

UNIVERSITÉ DE BOURGOGNE · FR

Inventors

Claude Gros · Paris, FR
Franck Gallardo · Bressols, FR
Nicolas Desbois · Bessey, FR

Key dates

Filing date	Nov 27, 2018
Grant date	Jul 26, 2022
Priority date	—
Expiry date	Jan 23, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a family of corroles for its use in the treatment of an infection by human herpesvirus, especially in the treatment of an infection by human cytomegalovirus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.